IFP Advisors’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $635K | Sell |
5,371
-964
| -15% | -$111K | 0.01% | 939 |
|
|
2026
Q1 | $757K | Sell |
6,335
-164
| -3% | -$21.5K | 0.02% | 796 |
|
|
2025
Q4 | $885K | Buy |
6,499
+186
| +3% | +$26.8K | 0.02% | 705 |
|
|
2025
Q3 | $931K | Buy |
6,313
+12
| +0.2% | +$1.66K | 0.02% | 625 |
|
|
2025
Q2 | $821K | Sell |
6,301
-258
| -4% | -$31.2K | 0.02% | 641 |
|
|
2025
Q1 | $784K | Sell |
6,559
-1,894
| -22% | -$235K | 0.02% | 618 |
|
|
2024
Q4 | $981K | Sell |
8,453
-631
| -7% | -$79.8K | 0.03% | 534 |
|
|
2024
Q3 | $1.23M | Buy |
9,084
+174
| +2% | +$23.3K | 0.04% | 425 |
|
|
2024
Q2 | $1.21M | Sell |
8,910
-313
| -3% | -$42.6K | 0.05% | 393 |
|
|
2024
Q1 | $1.19M | Sell |
9,223
-810
| -8% | -$97.9K | 0.05% | 373 |
|
|
2023
Q4 | $1.15M | Sell |
10,033
-1,245
| -11% | -$124K | 0.05% | 357 |
|
|
2023
Q3 | $1.03M | Sell |
11,278
-916
| -8% | -$94.5K | 0.05% | 380 |
|
|
2023
Q2 | $1.37M | Sell |
12,194
-214
| -2% | -$22.6K | 0.06% | 342 |
|
|
2023
Q1 | $891K | Sell |
12,408
-2,426
| -16% | -$253K | 0.04% | 424 |
|
|
2022
Q4 | $1.07M | Buy |
+14,834
| New | +$1.55M | 0.03% | 600 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 312 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 282 |
|
|
2022
Q1 | – | Sell |
-16,043
| Closed | -$1.54M | – | 282 |
|
|
2021
Q4 | $1.93M | Sell |
16,043
-2
| -0% | -$248 | 0.04% | 275 |
|
|
2021
Q3 | $1.99M | Buy |
16,045
+6
| +0% | +$772 | 0.04% | 264 |
|
|
2021
Q2 | $1.92M | Sell |
16,039
-251
| -2% | -$28.7K | 0.04% | 247 |
|
|
2021
Q1 | $1.72M | Sell |
16,290
-59
| -0.4% | -$5.98K | 0.03% | 256 |
|
|
2020
Q4 | $1.66M | Buy |
16,349
+38
| +0.2% | +$3.57K | 0.07% | 238 |
|
|
2020
Q3 | $1.37M | Buy |
16,311
+827
| +5% | +$64.4K | 0.08% | 231 |
|
|
2020
Q2 | $992K | Sell |
15,484
-1,181
| -7% | -$77.9K | 0.08% | 266 |
|
|
2020
Q1 | $1.13M | Buy |
16,665
+122
| +0.7% | +$9.61K | 0.11% | 195 |
|
|
2019
Q4 | $1.31M | Sell |
16,543
-164
| -1% | -$12.8K | 0.1% | 231 |
|
|
2019
Q3 | $1.33M | Buy |
+16,707
| New | +$1.31M | 0.09% | 249 |
|
|
2019
Q1 | $25K | Sell |
324
-26,620
| -99% | -$1.94M | ﹤0.01% | 1254 |
|
|
2018
Q4 | $1.76M | Sell |
26,944
-25
| -0.1% | -$1.73K | 0.11% | 214 |
|
|
2018
Q3 | $2.15M | Buy |
26,969
+2,681
| +11% | +$200K | 0.09% | 242 |
|
|
2018
Q2 | $1.64M | Buy |
24,288
+1,047
| +5% | +$76K | 0.07% | 296 |
|
|
2018
Q1 | $1.58M | Hold |
23,241
| – | – | 0.07% | 284 |
|
|
2017
Q4 | $1.58M | Sell |
23,241
-1,602
| -6% | -$106K | 0.07% | 285 |
|
|
2017
Q3 | $1.56M | Sell |
24,843
-120
| -0.5% | -$7.17K | 0.06% | 321 |
|
|
2017
Q2 | $1.38M | Buy |
24,963
+5
| +0% | +$260 | 0.06% | 342 |
|
|
2017
Q1 | $1.25M | Sell |
24,958
-896
| -3% | -$43.7K | 0.05% | 370 |
|
|
2016
Q4 | $1.28M | Buy |
25,854
+23,291
| +909% | +$1.18M | 0.06% | 336 |
|
|
2016
Q3 | $134K | Buy |
2,563
+74
| +3% | +$3.63K | 0.01% | 1202 |
|
|
2016
Q2 | $111K | Buy |
2,489
+2,165
| +668% | +$94.1K | 0.01% | 1266 |
|
|
2016
Q1 | $25K | Sell |
324
-39
| -11% | -$1.44K | ﹤0.01% | 1253 |
|
|
2015
Q4 | $13K | Buy |
+363
| New | +$13.1K | ﹤0.01% | 2448 |
|
Other funds holding XYL
IFP Advisors's XYL Position: Q2 2026 in Review
IFP Advisors reduced its Xylem (XYL) stake by 15% in Q2 2026, selling an estimated $111K and leaving 5,371 shares worth $635K. The position accounts for 0.01% of the portfolio, ranked #939.
IFP Advisors first reported a position in XYL in Q4 2015 and has held it in 39 quarters since. The position peaked at $2.15M in Q3 2018. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- IFP Advisors held 5,371 shares of Xylem worth $635K as of Q2 2026.
- IFP Advisors sold 964 Xylem shares in Q2 2026, an estimated $111K.
- Xylem made up 0.01% of IFP Advisors's portfolio in Q2 2026, its #939 holding.
- IFP Advisors first reported a position in Xylem in Q4 2015 and has held it in 39 quarters since.
- IFP Advisors's Xylem position peaked at $2.15M in Q3 2018.
- 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.